Skip to main content
OpenTrials

Clinical trial condition

Metastatic Colorectal Carcinoma

Explore clinical trials studying Metastatic Colorectal Carcinoma. Study availability and eligibility vary by location and protocol.

40 public trials 14 recruiting studies
Refine in advanced search Browse all conditions

Metastatic Colorectal Carcinoma trial results

Active, not recruiting

Testing the Addition of an Anticancer Drug, BAY 1895344, to the Usual Chemotherapy With FOLFIRI in Advanced or Metastatic Cancers of the Stomach and Intestines

NCT04535401

Conditions
Advanced Colorectal Carcinoma, Advanced Digestive System Carcinoma, Advanced Gastric Carcinoma, +24 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • National Cancer Institute Developmental Therapeutics Clinic Bethesda, Maryland, United States
  • National Institutes of Health Clinical Center Bethesda, Maryland, United States
  • Siteman Cancer Center at Saint Peters Hospital City of Saint Peters, Missouri, United States
View Trial Details
Active, not recruiting

Durvalumab and Tremelimumab With or Without High or Low-Dose Radiation Therapy in Treating Patients With Metastatic Colorectal or Non-small Cell Lung Cancer

NCT02888743

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +22 more
Locations
  • Mayo Clinic Hospital in Arizona Phoenix, Arizona, United States
  • Mayo Clinic in Arizona Scottsdale, Arizona, United States
  • Los Angeles General Medical Center Los Angeles, California, United States
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
View all 42 locations
View Trial Details
Active, not recruiting

Testing the PD-1 Antibody, MK3475, Given With Ziv-aflibercept in Patients With Advanced Cancer

NCT02298959

Conditions
Adenocarcinoma, Adnexal Diseases, Carcinoma, +60 more
Locations
  • Moffitt Cancer Center-International Plaza Tampa, Florida, United States
  • Moffitt Cancer Center - McKinley Campus Tampa, Florida, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • National Cancer Institute Developmental Therapeutics Clinic Bethesda, Maryland, United States
View Trial Details
Active, not recruiting

A Phase 1, Dose-escalation Study of [225Ac]-FPI-2068 in Adult Patients With Advanced Solid Tumours

NCT06147037

Conditions
Adenocarcinoma, Advanced Solid Tumor, Bronchial Neoplasms, +42 more
Locations
  • Research Site Palo Alto, California, United States
  • Research Site Chicago, Illinois, United States
  • Research Site Omaha, Nebraska, United States
  • Research Site Cleveland, Ohio, United States
View Trial Details
Active, not recruiting

BXQ-350 in Newly Diagnosed Metastatic Colorectal Carcinoma

NCT05322590

Conditions
Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +10 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • UC Irvine Health Orange, California, United States
  • Pacific Hematology Oncology Associates San Francisco, California, United States
  • Sylvester Comprehensive Cancer Center, University of Miami Hospitals and Clinics Miami, Florida, United States
View Trial Details
Active, not recruiting

TAS-102 and Oxaliplatin for the Treatment of Refractory Stage IV Colon Cancer

NCT04294264

Conditions
Colonic Diseases, Colonic Neoplasms, Colorectal Neoplasms, +15 more
Locations
  • Trinitas Hospital and Comprehensive Cancer Center Elizabeth, New Jersey, United States
  • RWJBarnabas Health - Monmouth Medical Center Southern Campus Lakewood, New Jersey, United States
  • Saint Barnabas Medical Center Livingston, New Jersey, United States
  • RWJBarnabas Health - Monmouth Medical Center Long Branch, New Jersey, United States
View Trial Details

Related conditions